Table 3.
Comorbidities according to the presence or absence of pneumonia.
Comorbidities, n (%) | Pneumonia | No Pneumonia | p-Value |
---|---|---|---|
Arterial hypertension | 41 (53.2) | 105 (53.6) | 0.961 |
Dyslipidemia | 40 (51.9) | 68 (34.7) | 0.009 ** |
Mellitus diabetes | 22 (28.6) | 44 (22.4) | 0.288 |
Atrial fibrillation | 13 (16.9) | 22 (11.2) | 0.229 |
Ischemic heart disease | 14 (18.2) | 24 (12.2) | 0.243 |
Heart failure | 17 (22.1) | 20 (10.2) | 0.017 * |
Peripheral vasculopathy | 5 (6.5) | 6 (3.1) | 0.302 |
Cerebrovascular disease | 0 (0.0) | 1 (0.5) | 1.000 |
Dementia | 1 (1.3) | 4 (2.0) | 1.000 |
Connective tissue disease | 2 (2.6) | 1 (0.5) | 0.193 |
Gastroduodenal ulcer | 6 (7.8) | 8 (4.1) | 0.229 |
Liver disease | 4 (5.2) | 12 (6.1) | 1.000 |
Hemiplegia | 0 (0.0) | 0 (0.0) | - |
Chronic kidney disease | 9 (11.7) | 14 (7.1) | 0.232 |
All neoplasia | 19 (24.7) | 56 (28.6) | 0.550 |
Lung cancer | 6 (7.8) | 18 (9.2) | 0.816 |
AIDS | 1 (1.3) | 0 (0.0) | 0.282 |
Anxiety | 0 (0.0) | 4 (2.0) | 0.580 |
Idiopathic pulmonary fibrosis | 0 (0.0) | 0 (0.0) | - |
Cirrhosis | 0 (0.0) | 0 (0.0) | - |
Comorbidity indices, median (IQR) | |||
Charlson | 2 (1–4) | 2 (1–3) | 0.099 |
COTE | 1 (1–3) | 0 (0–2) | 0.244 |
AIDS: acquired immune deficiency syndrome; * p < 0.05; ** p < 0.01.